akesa pharma

Activity value 76 australia Supplier,Last transaction date: 2026-01-16 Address: 18 ried way melbourn airport,australia au

Bill of lading data

< 1/15 >
  • Trade date 2026/01/16 B/L No. 2116680
  • Suppliers akesa pharma Buyers mepro pharmaceuticals pvt ltd.
  • POLs —— PODs ahmedabad
  • Supply area Australia Purchas area India
  • Weight —— Amount 81.12
  • Hs code 30049099 Product tags sami,faci,tablet,hydrochloride,blister pack,release
  • Product description INTUNIV GUANFACINE AS HYDROCHLORIDE 1 MG MOFIFIED RELEASETABLETS BLISTER PACK [28] B N AW5635AL3 0002210 [FOC SAMINTUNIV GUANFACINE AS HYDROCHLORIDE 1 MG MOFIFIED RELEASE Expand
+View All

Partners

Total 7

Products

Total 43
  • Products Transactions Per Detail
  • tablet
    10 71.43% >
  • film coated
    5 35.71% >
  • 8 tablet
    4 28.57% >
  • palbociclib
    3 21.43% >
  • ibra
    3 21.43% >
  • +View All

Hscode rank

Total 0
  • HSCode Name Transactions Per Detail
  • HS 30049099 14 100% >

Trading Area

Total 1
  • Area Transactions Per Detail
  • india 24 100.00% >

Port statistics

Total 1
  • Port Name Transactions Per Detail
  • melbourne 1 4.17% >
akesa pharma is australia Supplier,  and primarily engages in the import and export business of products such as tablet,film coated,8 tablet.  According to the 52wmb.com global trade database, as of 2026-01-16, the company has completed 24 international trades,  with its main trading regions covering india etc.  The core products include HS30049099 etc,  often transported via melbourne etc,  and its main trading partners are mylan laboratories ltd.,msn laboratories private,mepro pharmaceuticals pvt ltd..  These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.  They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development. They provide reliable support for cross-border trade decision-making.
The trade data displayed on akesa pharma is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis. We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.

Reference contact info


Email Hunting Tool

Whatsapp:+8616621075894(9:00 Am-18:00 Pm (SGT))

About us Contact us Advertise Buyer Supplier Company report Industry report

©2010-2026 52wmb.com all rights reserved